Impact of non‐obese metabolic dysfunction‐associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study
Shuhei Fukunaga(Kurume University), Takumi Kawaguchi(Kurume University), Dan Nakano(Kurume University), Taku Morita(Omuta hospital), Tsubasa Tsutsumi(Kurume University), Tsutomu Nagata(Kurume University), Tomoyuki Nakane(Kurume University), Akihiro Ohuchi(Kurume University), Hiroshi Tanaka(Kanagawa Institute of Technology), Ryuichi Nouno(Kumamoto Chuo Hospital), Michita Mukasa(Kurume University), Yoshinobu Okabe(Kurume University), Tomonori Chou(Kurume University), Ichiro Miyajima(Kurume University), Daiki Hayashi(Kurume University), Toshihiro Araki(Kurume University), Kota Takaki, Hiroshi Takaki(National Cerebral and Cardiovascular Center), Shinpei Minami(Kurume University), Takuji Torimura(Omuta hospital)
Cited by 22
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504